Skip to main content
. 2019 Oct 17;2:380. doi: 10.1038/s42003-019-0615-z

Fig. 7.

Fig. 7

High cytosolic calcium levels cause accumulation of cholesterol in late endosomes/lysosomes in the absence of spatacsin. a Quantification of the number of LAMP1-positive tubules in Spg11+/+ and Spg11−/− fibroblasts expressing LAMP1-mCherry, analyzed by live imaging. The graphs show the mean ± SEM. N > 60 cells analyzed in four independent experiments. Two-way ANOVA: *p = 0.034, ***p < 0.0001. b Western blots of TFEB in cytosolic and nuclear fractions of Spg11+/+ and Spg11−/− fibroblasts transfected with control siRNA or a specific siRNA that downregulates TFEB. c Quantification of the number of LAMP1-positive tubules in Spg11+/+ and Spg11−/− fibroblasts transfected with control siRNA or siRNA that downregulates TFEB. The graph shows the mean ± SEM. N > 60 cells analyzed in four independent experiments. Two-way ANOVA: ***p < 0.0001. d Downregulation of STIM1 decreases the amount of cholesterol colocalized with LAMP1 in Spg11−/− fibroblasts. The graph shows the mean ± SEM. N > 95 cells analyzed in three independent experiments. Two-way ANOVA: ***p < 0.001. e Lowering intracellular calcium levels with EGTA-AM (1 h) decreases the amount of cholesterol colocalized with LAMP1 in Spg11−/− fibroblasts. The graph shows the mean ± SEM. N > 45 cells analyzed in three independent experiments. Two-way ANOVA: ***p < 0.001. f Downregulation of TFEB decreases the amount of cholesterol colocalized with LAMP1 in Spg11−/− fibroblasts. The graph shows the mean ± SEM. N > 45 cells analyzed in three independent experiments. Two-way ANOVA: *p < 0.05. g Quantification of plasma membrane cholesterol with the probe GFP-D4, performed on live Spg11+/+ and Spg11−/− fibroblasts, showing that downregulation of STIM1 restores normal levels of cholesterol in the plasma membrane in Spg11−/− fibroblasts. The graph shows the mean ± SEM. N > 180 cells analyzed in three independent experiments. Two-way ANOVA: ***p < 0.0001